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Abstract 
Background: Neuromuscular disorders (NMD) commonly affect the upper extremity. Due to muscle weakness, 
performance of daily activities becomes increasingly difficult, which leads to reduced independence and quality of 
life. In order to support the performance of upper extremity tasks, dynamic arm supports may be used. The Yumen 
Arm is a novel dynamic arm support specially developed for people with NMD. The aim of this study is to evaluate the 
feasibility and effectiveness of the Yumen Arm in persons with Duchenne Muscular Dystrophy (DMD) and persons 
with Spinal Muscular Atrophy (SMA).
Methods: Three persons with DMD and three persons with SMA participated in this study. All participants conducted 
a set of measures with and without the Yumen Arm. Outcome measures were: active range of motion of the arm 
and trunk (i.e. Reachable Workspace, Functional Workspace, and trunk movement), fatigue (OMNI-RPE), Performance 
of Upper Limb (PUL) scale and some additional activities of daily living. User experiences were collected using a 
questionnaire.
Results: The Yumen Arm could be used by all participants. Results showed a median increase in active range of 
motion (4% relative surface area), and a median increase of function ability (> 11% PUL score) when using the Yumen 
Arm. In addition, three out of four (data from 2 participants was missing) participants indicated that activity perfor-
mance was less fatiguing when using the Yumen Arm. Four out of five (data from 1 participant was missing) partici-
pants indicated that they would like to use the Yumen Arm in their daily lives.
Conclusion: This study is one of the first studies describing a range of objective measures to examine the effective-
ness of a dynamic arm support. Based on these measurements we can conclude that the Yumen Arm effectively 
improves arm function in NMD patients, however the effectiveness varies a lot between individual subjects. We 
provided detailed recommendations for the improvement of the Yumen Arm, and possible also for the development 
of other dynamic arm supports. This study showed a lot of variability between individual subjects, which emphasizes 
the importance of tuning dynamic arm supports based on individual user characteristics, such as scoliosis, functional 
capacity and muscle strength.
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Background
Worldwide there are over 600 different neuromuscu-
lar disorders (NMD) with an estimated total prevalence 
of > 160/100.000 people [1]. In a large part of these dis-
orders the upper extremity is affected [2]. Due to upper 
extremity muscle weakness, many patients with NMD 
have difficulties performing daily activities with the arms 
and hands. Upper extremity limitations are severely disa-
bling and have great impact on independence and quality 
of life, especially as many NMD patients are wheelchair 
users [3]. Consequently, there is a need for treatment 
options that can improve upper extremity function in 
NMD patients. As most NMD do not have a cure yet, and 
medication can only delay upper extremity limitations by 
several years, improvement of upper extremity function 
can mainly be achieved using assistive technology, such 
as dynamic arm supports.
Over the past decades several (semi)passive dynamic 
arm supports, such as the Mobile Arm support (MAS) 
and Wilmington Robotic EXoskeleton (WREX), by 
JAECO Orthodedic), the Armon Ayura (Microgravity 
Products), the TOP/HELP and Darwing (Focal Med-
itech), and many more have been developed and tested 
[4–6]. Despite the fact that most of the dynamic arm sup-
ports that were studied improved the ability to perform 
activities of daily living, the use of dynamic arm supports 
in the home situation was reported low [4]. Although 
more research on this topic should be performed, sev-
eral factors that could contribute to the low home use of 
dynamic arm supports are already identified [7, 8]. These 
factors can be divided in: personal factors, aesthetics, 
environmental factors, costs and additional factors. Per-
sonal factors are for example: user satisfaction (both with 
regard to the device and the services), inability to use 
compensatory mechanisms, difficulties in use, and clini-
cal deterioration [8]. Aesthetics of the arm support are 
important for acceptance of the device. The functionality 
gained with the dynamic arm supports should outweigh 
its expense and appearance, especially for children and 
adolescents with NMD [9]. Environmental factors are for 
example: customer service (i.e. problem solving related 
to the device) and use of a manual wheelchair. In unpub-
lished data of our own research group, manual wheel-
chair users stated that existing arm supports did not have 
the required range of motion to operate the wheelchair. 
Finally, most arm supports only provide unilateral sup-
port and restrict trunk movement, which limits the range 
of motion of the arms [10]. Many daily activities require 
trunk movement to reach for objects, or require the use 
of both arms or hands (bimanual tasks). The inability to 
support these tasks also leads to low home use.
In order to overcome some of the factors for non-use 
of arm supports and to optimize the effectiveness of arm 
supports for NMD patients, Yumen Bionics (Amsterdam, 
the Netherlands) developed a novel dynamic arm sup-
port; the Yumen Arm. The design of this arm support 
was based on a previous prototype, the passive A-Gear, 
which was developed for and tested with Duchenne Mus-
cular Dystrophy (DMD) patients by our research group 
[11]. This previous study involved 3 boys with DMD and 
demonstrated that the A-gear prototype enabled them, 
for example, to independently drink a glass of water, 
raise and wave their arms, and move the wheels of their 
wheelchair. These tasks where not possible without the 
device or only for a very limited time [11]. Since the 
development of the passive A-Gear many improvements 
have been made in the design, such as an added free 
trunk movement structure, a slimmer spring configura-
tion and the exoskeleton is adjustable to all sizes. The 
Yumen Arm has some unique features in comparison to 
some of the commercially available arm supports, such 
as (1) the Yumen Arm always supports both arms, which 
could increase the performance of bimanual tasks, (2) the 
Yumen Arm has a large range of motion, which allows 
users to still use their manual wheelchair, (3) the Yumen 
Arm has a soft/fabric lower arm cup, which reduces 
interference of the device with the environment, for 
example during handwriting, (4) the joints of the Yumen 
Arm are aligned with the user, which allows for natu-
ral movements, and (5) the Yumen Arm is scalable and 
placed close to the body, which reduces conspicuousness 
and improves aesthetics.
The aim of this study is to evaluate the feasibility and 
effectiveness of the Yumen Arm in persons with Duch-
enne Muscular Dystrophy (DMD) and persons with Spi-
nal Muscular Atrophy (SMA). We hypothesize that the 
Yumen Arm will improve upper extremity function in 
persons with DMD and SMA and that the Yumen Arm 
will reduce fatiguability. We choose to study effectiveness 
of the Yumen Arm in both DMD and SMA patients as 




The Yumen Arm is a statically balanced passive dynamic 
support developed by the startup company Yumen Bion-
ics (Fig.  1). Yumen Bionics derives its name from the 
Keywords: Duchenne muscular dystrophy, Spinal muscular atrophy, Upper limb, Dynamic arm support
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words yume (Japanese for dreams) and human. The com-
pany was founded to translate the results of academic 
projects to products that can be brought to the market. 
The goal of Yumen Bionics is to help people with muscle 
weakness pursue their dream of moving independently 
again by offering assistive technology such as the Yumen 
Arm.
The mechanical design of the Yumen Arm is based 
on the prototype that has been developed as part of the 
A-gear project within the Flextension initiative [11]. This 
design uses strategically placed springs to maintain a 
static balance, a concept first described by Lin et al. [13]. 
This design ensures a force equilibrium in every possible 
position in the complete range of motion of the structure. 
The springs used in the Yumen Arm are bands of poly-
isoprene rubber with a linear range of 100% to 220% of 
the bands length. Rubber bands were chosen because of 
the extremely high strain energy density compared to 
metal torsion springs (16 J/cm3 versus 0,3 J/cm3 in metal 
torsion springs). The strain energy requirements of the 
exoskeleton requisites the use of rubber, as metal tor-
sion springs would require more volume than there is 
available between the shoulder and the lower arm. Per 
participants a set of rubber bands is selected to realize 
around 70% compensation of their estimated arm weight. 
This percentage was chosen based on previous qualita-
tive user research. Participants indicated that support 
of more than 70% of the arm weight felt less natural and 
less intuitive, while compensation of less than 70% of 
the estimated arm weight required to much effort. The 
rubber bands were selected for every participant indi-
vidually and we tested the spring configuration during a 
fitting session. In this way, the weight of the arm that the 
participants have to lift actively is reduced significantly, 
thereby allowing more muscle force to be used for move-
ment of the arm in order to carry out daily tasks, and/or 
doing those tasks for a longer time. The Yumen Arm is 
fixed to the wheelchair using a spring balanced mecha-
nism that balances the lifted weight of the patients arm 
plus the weight of the exoskeleton arms itself. This allows 
the patient to use the exoskeleton without extra weight 
on their shoulders. In addition, the structure remains 
close to the body and allows free movement of the trunk 
when seated in the wheelchair. The Yumen Arm can be 
adjusted to the dimensions of individual participants by 
adjusting the length of the upper arm part, the width of 
the lower arm arch, and the width of the connector at the 
back of the participants. The primary target population 
of the Yumen Arm are people with neuromuscular disor-
ders and other flaccid paresis, that use a wheelchair.
Population
In total 3 boys with DMD and 3 persons with SMA (2 
female, 1 male) participated in the study. Participants 
were included if they had a DNA established diagnosis 
of DMD or SMA, and if they had a score of 2–4 on the 
Brooke upper extremity rating scale [14]. Participants 
were excluded if they were younger than 7 years of age, 
or if they had other disabling diseases that affected their 
upper extremity. Participants were recruited by advertise-
ment through patient organizations “Spierziekten Neder-
land”, “Prinses Beatrix Spierfonds” and “Duchenne Parent 
Project”. This study was approved by the medical ethical 
committee Arnhem–Nijmegen, the Netherlands (Reg-
istration Number 2016–2824, NL nr.: NL58988.091.16). 
Informed consent was obtained before the start of the 
study from all participants and from their parents when 
the participants were under 16 years of age.
Fig. 1 Yumen arm. a Design sketch without elastic bands, b Prototype fitted on one of the participants
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Table  1 shows the characteristics of the participants 
in this study. Three persons with DMD and three per-
sons with SMA were included. Brooke upper extremity 
functional rating scale varied between 2 (can raise arms 
above head only by flexing the elbow or using accessory 
muscles) to 4 (can raise hands to mouth, but cannot raise 
an 8-oz glass of water to the mouth). Next to the large 
differences in functional status, the study population 
also showed large variability in age, height and weight. 
Furthermore, participants had different experience lev-
els with regard to the use of dynamic arm supports. For 
some participants it was their first experience with a 
dynamic arm support, while other participants already 
used a commercially available arm support in their daily 
lives.
Procedures
When participants agreed to participate, the researcher 
and technicians from Yumen Bionics visited the partici-
pants at their homes to take anthropometric dimensions 
of the arm and trunk and to do a first fitting of the Yumen 
Arm. After this visit adjustments were made to the proto-
type in order to match the dimensions of the Yumen Arm 
to the dimensions of the individual participants. During 
a revisit, the dimensions were checked and the correct 
amount of supports for balancing the arm against gravity 
was set by adjusting the number of elastic bands. After 
the revisit additional changes were made to the Yumen 
Arm if necessary. Finally, participants visited the move-
ment laboratory of the Radboudumc (Nijmegen, the 
Netherlands) for the evaluation of the Yumen Arm in a 
standardized environment. During this evaluation all 
participants performed a series of measurements, first 
without the Yumen Arm and then with the Yumen Arm. 
In between measurements there was a break of about 1 h 
to give the participants the opportunity to rest and mini-
mize the effects of fatigue.
Measurements/outcome measures
For the evaluation of the Yumen Arm we measured par-
ticipant characteristic, such as age, disorder, SMA-type, 
occurrence of scoliosis, Brooke Upper Extremity rat-
ing scale [14], weight, height and wheelchair type. We 
also report the fit of the Yumen Arm as estimated by 
the researchers. Quality of fit was scored as good, mod-
erate or bad, based on the relation between segment 
lengths and joint alignment of the Yumen Arm relative 
to the participants anatomy. In addition, we used out-
come measures on the International Classification of 
Functioning, disability and health (ICF) level of body 
functions and structures and on ICF activity level [15]. 
All outcome measures were aimed to investigate the 
capacity of the user with and without using the Yumen 
Arm. Outcome measures on the ICF level of body func-
tions and structures were active range of motion of the 
arm and trunk, and fatigue. Outcome measures on the 
ICF activity level were the Performance of Upper Limb 
(PUL) scale and some additional activities of daily liv-
ing that were not captured within the PUL. All tasks 
were performed once per condition (with and without 
arm support). All participants were measured in their 
own wheelchair with back support.
Fatigue
Fatigue was examined using the OMNI Rating of Per-
ceived Exertion (OMNI-RPE) scale, an 11-point scale, 
where 0 indicates ‘not tired at all’ and 10 indicates ‘very, 
very tired’ [16]. Participants were asked to score their 
level of experienced fatigue before and after the meas-
urements with and without the Yumen Arm. We specif-
ically asked participants to indicate the muscle fatigue 
experienced in the arms.
Table 1 participant characteristics
Subject 1 Subject 2 Subject 3 Subject 4 Subject 5 Subject 6
Diagnosis DMD DMD SMA DMD SMA SMA
Gender Male Male Female Male Female Male
Age (year) 14 18 41 11 11 28
Handedness Right Left Right Right Right Right
Scoliosis No Mild Severe (had surgery) No Severe (had surgery) Severe (had surgery)
Brooke scale 3 4 4 2 4 3
Weight (kg) 72 46 66 63 29 110
Height (m) 1.65 1.56 1.57 1.65 1.33 1.92




Electric Manual with 
power assist
Electric Electric
Fit of Yumen Arm Good Moderate Bad Good Bad Moderate
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Range of motion
In order to gain insight in the range of motion of the 
arms and trunk, three different tasks were used. First, 
we measured reachable workspace of the hand relative to 
the shoulder using the reachable workspace analysis [17]. 
Secondly, we measured the functional workspace (abil-
ity to reach close to the body), which was an option of 
reachable workspace software developed by Kurillo and 
Han et al. [18]. Finally, we measured compensatory trunk 
movements during the performance of daily activities.
Reachable workspace
Reachable workspace analysis is an outcome measure 
closely related to shoulder range of motion and it is quite 
commonly used in neuromuscular disorders [17, 19]. In 
contrast to using the Microsoft Kinect, which is normally 
used for the reachable workspace analysis, we used a 
10-camera VICON motion analysis system (Oxford Met-
rics, Oxford, UK) to capture 3D positions of the upper 
extremity joints with a sample frequency of 100  Hz. 
Twenty-four external reflecting markers (ø 14 mm) were 
placed according to the Upper Limb Model product 
guide (Revision 1.0 July 2007). Reachable workspace (i.e. 
relative surface area representing the portion of the unit 
hemisphere that is covered by the hand movement) was 
calculated by using the joint locations from the VICON 
system as input for the reachable workspace software 
[18]. Next to the full relative surface area (RSA), the RSAs 
per quadrant (upper medial and lateral, lower medial 
and lateral) were calculated. The full RSA has a maximal 
value of 1, which is scored if the hand is able to reach all 
parts of the circle around the shoulder at 1 arm length. In 
addition, the absolute total and quadrant reachable work-
space surface envelope areas  (m2) (ASA) were calculated. 
Reachable workspace analysis was performed with both 
the left and right arm.
Functional workspace
The functional workspace analysis was performed with 
both the right and left hand and consisted of 7 move-
ments in which the participants were asked to touch 
the following close to body locations: belly button, back 
pocket, ipsilateral shoulder, contralateral shoulder, 
mouth, top of the head and back head [20]. As there was 
no standardized and automated method for analyzing 
the functional workspace at the time of this study, we 
analyzed the results manually based on video recordings 
(videos of the frontal and sagittal plane were recorded). 
For each target a score of 0–3 was awarded by the exam-
iner: 0 = the participants was not able to perform the 
task, 1 = the participant was able to reach to 0–49% of 
the target position, 2 = the participant was able to reach 
to 50–99% of the target position, and 3 = the participant 
was able to fully reach the target position. Next to the 
score for each target separately a sum score for all targets 
was calculated.
Compensatory trunk movement
In order to gain insight in the compensatory mechanisms 
used with and without the Yumen Arm, we measured the 
amount of trunk movement during the performance of 
three daily tasks, i.e. drink, move a 100 g weight, and use 
the keyboard of a computer. Increased trunk movement 
during task performance is a commonly used compen-
satory strategy [11, 21]. We measured trunk movement 
based on the normalized (for task duration) 3D move-
ment (mm) of a reflective marker placed on the jugular 
notch during task performance.
Functional ability
Functional ability was examined using the high level-
shoulder and mid-level-elbow dimensions of the perfor-
mance of upper limb (PUL) scale [22]. PUL items were 
performed with both hands separately in case of uni-
lateral tasks, for bimanual tasks both hands were used 
simultaneous. In addition to the PUL items we exam-
ined 6 extra daily activities (i.e. using the keyboard of a 
computer, eating with knife and fork, shaking hands (left 
and right), writing, flip through pages of a book and use 
a manual wheelchair (if applicable)). These activities were 
in our opinion not captured in items of the PUL, and they 
were indicated as important and impaired daily activities 
by DMD patients in previous research [23]. PUL items 
were scored based on the instruction manual (PUL for 
DMD 2.0 Clinical Evaluator Manual) and the additional 
items were awarded a score from 0 to 2 (0 = not able, 
1 = able using compensatory movements, 2 = able with-
out compensatory movements). Scores for the individual 
items and sum scores were calculated.
User experiences
After the measurements were finished, all participants 
were asked to fill out a questionnaire in order to gain 
insight in their user experiences with the Yumen Arm. 
The topics of the questionnaire were related to: range 
of motion, amount of support, stability, safety (pressure 
points, risks of pinching the skin, risk of involuntary 
movements and risk of the arm falling out of the device), 
comfort, fatigue, aesthetics, donning and doffing, clean-
ing, compatibility with other devices and interest in using 
the device in daily life.
Statistical analysis
This study is setup as a case series, meaning that obser-
vations are made on a series of individuals, all receiving 
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the same intervention [24]. We compared the results with 
and without using the Yumen Arm separately for each 
participant by using descriptive data. Effectiveness of the 
Yumen Arm is measured by comparing the change with 
and without use of the Yumen Arm for all outcome meas-
ures. No group statistics were performed.
Results
Table  2 shows the results of fatigue. Median fatigue 
scores increased with 2.0 points on the OMNI-RPE scale 
while participants were performing the measurements 
without the arm support. When using the Yumen Arm 
the median fatigue level increased with 1.5 points on the 
OMNI-RPE scale while performing the measurements. 
There is a large variability between the experienced 
fatigue of participants, as some subjects experienced 
hardly any fatigue (subjects 1 and 2) and some subjects 
experienced relatively high levels of fatigue (subjects 
3–6).
Table  3 shows the results of the reachable workspace 
analysis. The RSA of the right arm improves in 4 out of 
6 participants, and de RSA of the left arm improves in 
5 out of 6 participants when using the Yumen Arm. The 
ASA improves in 2 out of 6 participants for the right arm 
and in 4 out of 6 participants for the left arm. There is 
a large variability in the change of reachable workspace 
between participants. Figure 2a shows an example of the 
reachable workspace of subject 1, who clearly improves 
when using the Yumen Arm. Figure 2b shows an exam-
ple of the reachable workspace of subject 4, who does 
Table 2 Fatigue based on OMNI-RPE scores
Subject Without Yumen Arm With Yumen Arm
Pre test Post test Difference post–pre 
test
Pre test Post test Difference 
post–pre 
test
Subject 1 0 2 2 1 2 1
Subject 2 0 1 1 2.5 3 0.5
Subject 3 3.5 5.5 2 4 5 1
Subject 4 3.5 5.5 2 4.5 6.5 2
Subject 5 3.8 7.2 3.4 4.7 7.3 2.6
Subject 6 2.3 4.7 2.4 2.8 5.3 2.5
Median (range) 2.9 (0; 3.8) 5.1 (1; 7.2) 2.0 (1; 3.4) 3.4 (2; 7.3) 5.2 (2; 7.3) 1.5 (0.5; 2.6)
Table 3 Reachable workspace
Right arm Left arm
Without support With support Difference with-
without support
Without support With support Difference with-
without support
Relative surface area
 Subject 1 0.03 0.14 0.11 0.04 0.12 0.08
 Subject 2 0.20 0.16 − 0.04 0.17 0.17 0.00
 Subject 3 0.06 0.15 0.09 0.07 0.12 0.05
 Subject 4 0.19 0.20 0.01 0.10 0.23 0.13
 Subject 5 0.08 0.05 0.02 0.04 0.05 0.01
 Subject 6 0.16 0.19 0.03 0.14 0.21 0.07
Median (range) 0.12 (0.09;0.37) 0.16 (0.05;0.20) 0.02 (− 0.04;0.11) 0.09 (0.04;0.17) 0.15 (0.05;0.23) 0.06 (0.00;0.13)
Absolute surface area  (m2)
 Subject 1 0.05 0.22 0.17 0.06 0.17 0.11
 Subject 2 0.33 0.25 − 0.07 0.26 0.20 − 0.05
 Subject 3 0.11 0.26 0.15 0.12 0.15 0.03
 Subject 4 0.36 0.34 − 0.02 0.18 0.31 0.13
 Subject 5 0.09 0.07 − 0.02 0.04 0.04 0.00
 Subject 6 0.37 0.36 0.00 0.28 0.37 0.08
Median (range) 0.22 (0.09;0.37) 0.26 (0.07;0.36) − 0.01 (− 0.07;0.17) 0.15 (0.04;0.28) 0.19 (0.04;0.37) 0.06 (0.00;0.13)
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not improve using the Yumen Arm. When looking at the 
changes per quadrant, the largest improvement in reach-
able workspace due to use of the Yumen Arm can be seen 
in quadrant 2, the lower medial quadrant (indicated by 
the green area in Fig. 1). Complete results of the reach-
able workspace analysis including changes in each quad-
rant are available in Additional file 1: Appendix A1 and 
A2.
Table  4 shows the results of the functional work-
space analysis. The participants’ score as percentage of 
the maximal possible score is displayed. For the right 
arm, the ability to reach close to the body increased 
in 2 participants, did not change in 3 participants 
and decreased in 1 participant. For the left arm, the 
ability to reach close to the body increased in 4 par-
ticipants and did not change in 2 participants. Look-
ing at the scores of individual targets, we see that the 
ability to touch the top of the head and touch the ipsi-
lateral shoulder improves for some participants, while 
the ability to touch the back pocket decreases when 
using the Yumen Arm. The ability to touch the mouth 
improves in some participants, but decreases in other 
participants when using the Yumen Arm. Results for 
individual targets of the functional workspace analysis 
can be found in Additional file 2: Appendix B.
Figure  3 shows the trunk movement (i.e. displace-
ment of a marker on the sternum) that was made dur-
ing the performance of 5 tasks (drinking with the left 
and right hand, moving a 100 g weight across the table 
with the left and right hand, and the keyboard of a 
computer). In general, participants use more trunk 
movement while performing the tasks without support, 
compared to with support.
Fig. 2 Reachable workspace with and without Yumen Arm. a example of subject 1, where the reachable workspace improves due to use of the 
Yumen Arm. b example of subject 4, where the reachable workspace remains unchanged when using the Yumen Arm
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Both the results of the PUL and the additional daily 
activities are displayed in Table  5. Results of the PUL 
are expressed as the percentage of the maximal possible 
score for the high level-shoulder dimension, mid-level-
elbow dimension and the score of the shoulder and 
elbow dimension together. Also, the total sum score of 
the additional activities are expressed as percentage of 
the maximal possible score. In total, we saw a median 
improvement of 14.5% for the right arm (equal to 4.5 
points improvement) and a median improvement of 
6.5% for the left arm (equal to 2.0 points improvement) 
when subjects where using the Yumen Arm to perform 
items of the PUL. For the additional activities we saw 
median improvements of 15.0% in both arms. None 
of the participant showed a decline in function when 
using the Yumen arm. Here also, there is a lot of vari-
ability between participants, as some participants show 
improvements up to 20% on PUL items and even 50% 
on the additional activities, while others did not show 
any functional improvement. When looking at individ-
ual items of the PUL, we saw that scores of abduction 
and flexion of the arm to shoulder height and moving 
a weight across the table increased most when par-
ticipants use the Yumen Arm. The additional activi-
ties that showed largest improvement when using the 
Yumen Arm are shaking hands and turning pages of 
a book. Scores for individual items of the PUL can be 
found in Additional file  3: Appendix C1 and scores of 
Table 4 Functional workspace
Right arm Left arm
Without support With support Difference with-
without support
Without support With support Difference with-
without support
Percentage of maximal possible score (%)
 Subject 1 61.9 61.9 0.0 61.9 66.7 4.8
 Subject 2 61.9 71.4 9.5 61.9 66.7 4.8
 Subject 3 61.9 71.4 9.5 61.9 66.7 4.8
 Subject 4 66.7 57.1 − 9.5 38.9 61.9 28.6
 Subject 5 66.7 66.7 0.0 66.7 66.7 0.0
 Subject 6 66.7 66.7 0.0 66.7 66.7 0.0
Median (range) 64.3 (61.9;66.7) 66.7 (57.1;71.4) 0.0 (− 9.5;9.5) 61.9 (38.9;66.7) 66.7 (61.9;66.7) 4.8 (0.0;28.6)
Fig. 3 compensatory movement of the trunk (mm) during task performance with and without support. Trunk movement is defined as the absolute 
distance covered (mm) by the marker on the jugular notch during the following activities. Drink right: bring hand holding a cup with 200 g to the 
mouth with the right arm; Drink left: bring hand holding a cup with 200 g to the mouth with the left arm; Weight right: move a 100 g weight across 
the table from the shoulder line to the center of the body with the right arm; Weight left: move a 100 g weight across the table from the shoulder 
line to the center of the body with the left arm; Computer: use both hands on the keyboard of the computer to write a word
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individual added activities can be found in Additional 
file 3: Appendix C2.
User experiences were examined using a questionnaire. 
The results from this questionnaire showed that partici-
pants experienced movements directing upward, side-
ward and forward as easier, because the Yumen Arm’s 
elastic bands helped in this direction. Movements direct-
ing downward and backward were experienced as more 
difficult when using the Yumen Arm, because the par-
ticipants had to exert force in these directions as gravity 
was compensated and the arm had to be brought down 
actively. With regard to safety, most participants indi-
cated that there were no pressure points, nor pinching 
of the skin, although one participant pointed out that the 
Yumen Arm pressed against the shoulder and another 
participant felt the skin was pinched between the Yumen 
Arm in the table near the elbow (Subject 3). In addition, 
the Yumen Arm did not collide with the wheelchair or 
table, but it sometimes collided with other parts of the 
body, for example the trunk or shoulder. Two partici-
pants indicated that the Yumen Arm sometimes moved 
to a certain position, while this was not an intended 
movement. None of the participants thought that the 
arm could fall out of the support. With regard to com-
fort most participants indicated that the Yumen Arm was 
comfortable and fitted well. The surface of the arm cup 
Table 5 Functional ability as percent of maximal possible score (%)
Right arm Left arm
Without support With support Difference with-
without support
Without support With support Difference with-
without support
PUL shoulder dimension
 Subject 1 0.0 8.3 8.3 0.0 8.3 8.3
 Subject 2 8.3 25.0 16.7 8.3 16.7 8.3
 Subject 3 0.0 0.0 0.0 0.0 0.0 0.0
 Subject 4 8.3 16.7 8.3 0.0 16.7 16.7
 Subject 5 0.0 0.0 0.0 0.0 0.0 0.0
 Subject 6 0.0 16.7 16.7 0.0 8.3 8.3
Median (range) 0.0 (0.0;8.3) 12.5 (0.0;25.0) 8.3 (0.0;16.7) 0.0 (0.0;8.3) 8.3 (0.0;16.7) 8.3 (0.0;16.7)
PUL elbow dimension
 Subject 1 36.8 57.9 21.1 31.6 57.9 26.3
 Subject 2 57.9 68.4 10.5 57.9 57.9 0.0
 Subject 3 57.9 57.9 0.0 42.1 47.4 5.3
 Subject 4 52.6 73.7 21.1 47.4 68.4 21.1
 Subject 5 5.3 15.8 10.5 15.8 15.8 0.0
 Subject 6 63.2 78.9 15.8 63.2 73.7 10.5
Median (range) 55.3 (5.3;63.2) 63.2 (15.8;78.9) 13.2 (0.0;21.1) 44.7 (15.8;63.2) 57.9 (18.5;73.7) 7.9 (0.0;26.3)
PUL shoulder and elbow dimension
 Subject 1 22.6 38.7 16.1 19.4 38.7 19.4
 Subject 2 38.7 51.6 12.9 38.7 41.9 3.2
 Subject 3 35.5 35.5 0.0 25.8 29.0 3.2
 Subject 4 35.5 51.6 16.1 29.0 48.4 19.4
 Subject 5 3.2 9.7 6.5 9.7 9.7 0.0
 Subject 6 38.7 54.8 16.1 38.7 48.4 9.7
Median (range) 35.5 (3.2;38.7) 45.2 (9.7;54.8) 14.5 (0.0;16.1) 27.4 (9.7;38.7) 40.3 (9.7;48.4) 6.5 (0.0;19.4)
Additional daily activities
 Subject 1 50.0 100.0 50.0 50.0 91.7 41.7
 Subject 2 83.3 91.7 8.3 83.3 83.3 0.0
 Subject 3 60.0 80.0 20.0 60.0 80.0 20.0
 Subject 4 75.0 100.0 25.0 66.7 100.0 33.3
 Subject 5 40.0 40.0 0.0 40.0 40.0 0.0
 Subject 6 90.0 100.0 10.0 90.0 100.0 10.0
Median (range) 67.5 (40.0;90.0) 95.8 (40.0;100.0) 15.0 (0.0;50.0) 63.3 (40.0;90.0) 87.5 (40.0;100.0) 15.0 (0.0;41.7)
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felt soft, although for some participant the hard edges 
of the arm cup near the elbow were a little uncomfort-
able. With regard to the aesthetics of the arm support 
participants had varying opinions, but in general they all 
stated that the aesthetics of the Yumen Arm can still be 
improved. The arm cup was liked by most participants, 
but the elastic bands were disliked. The metal struc-
ture was best appreciated when colored black instead of 
metal. Donning and doffing of the arm support was fairly 
fast and could most of the time be done within three min-
utes. Setting up the arm support for testing and finding 
the correct balance (one-time only setup), however took 
much longer (up to 45 min). With regard to compatibil-
ity participants indicated that it would be hard to use the 
Yumen Arm in combination with a patient hoist, but that 
the Yumen Arm would be compatible with a PEG probe 
or a tracheostoma. Finally, 75%, i.e. 3 out of 4 participants 
(data from 2 participants was missing) of the participants 
indicated that moving the arm when using the Yumen 
Arm required less energy and therefore was less fatigu-
ing. Four out of five participants, i.e. 80% (data from 1 
participant was missing) indicated that they would be 
willing to use the Yumen Arm at home during daily life.
Discussion
The aim of this study was to evaluate the feasibility and 
effectiveness of the Yumen Arm in people with DMD and 
SMA. With regard to feasibility all participants were able 
to fit the Yumen Arm after two fitting sessions, which 
was also indicated in the questionnaire, where 5 out of 6 
participants stated that the Yumen Arm fitted well. Yet, 
the quality of fit as scored by the researchers differed a 
lot between de subjects (Table 1). The Yumen Arm was 
originally developed for boys with DMD and during the 
fitting process we indeed saw that the prototype fitted 
better in boys with DMD compared to the SMA patients. 
Important factors for the prototype not fitting as well in 
SMA patients were: scoliosis, gender and variability in 
body dimensions. In contrast to the DMD patients, all 
SMA patients suffered from severe scoliosis. As a result, 
SMA patients had difficulties with sitting upright and 
their shoulder height was not at the same level for the left 
and right shoulder. This asymmetry led to a worse fit of 
the Yumen Arm. Gender was important during the fit-
ting process, as it appeared that the chest strap did not fit 
well in the adult female participant. Finally, the large vari-
ability in body dimensions of the SMA patients (height 
varied from 133 to 192  cm and weight varied from 29 
to 110 kg) led to difficulties with the correctly fitting the 
Yumen Arm. The DMD patients included showed much 
more homogeneity in terms of age, gender and body 
dimensions and therefore the Yumen Arm was easier to 
fit in this population. Difficulties with fitting were mainly 
present in subject 3 and subject 5, the female SMA 
patients, who also showed the lowest functional benefit. 
In order to ensure feasibility of the Yumen Arm in SMA 
patients, future design adaptations have to be made to 
meet the specific needs of SMA patients, such as removal 
of the chest strap, building in adjustment options for 
patients with asymmetric shoulder height and optimize 
fitting with regard to joint alignment.
To examine the effectiveness of the Yumen Arm, we 
evaluated fatigue, range of motion, functional ability and 
user satisfaction. Subjectively, participants indicated that 
less energy was required to move the arm while using 
the Yumen Arm. In addition, the OMNI-RPE scores did 
increase less while performing the measurement with the 
Yumen Arm compared to the measurement without the 
Yumen Arm. Hereby it should be noted that all pre-test 
fatigue levels were higher before the test with the Yumen 
Arm, which is probably due to the fact that the break 
between the measurements was not sufficient to fully 
recover from the measurement without the Yumen Arm. 
Future studies should ensure that fatigue at the start of 
a measurement is not different between conditions, 
for example by randomizing the order in which differ-
ent conditions are examined. In addition, future studies 
should focus on objective evaluation of fatigue levels, for 
example by looking at the ability to perform tasks repeat-
edly or by looking at muscle activity changes during 
fatiguing tasks, as dynamic arm supports could play an 
important role in reducing daily life fatigue.
Regarding range of motion, we saw varying results. 
Reachable workspace did increase in most of the partici-
pants (4 out of 6) when using the Yumen Arm, but with 
a median RSAs of 0.16 (left and right arm combined) 
when using the Yumen Arm, participants are only able 
to reach a small percentage of their total workspace. In 
addition, the ability to reach targets close to the body 
(functional workspace) shows a median increase of only 
2.4 percent (left and right arm combined). Nevertheless, 
we saw some promising increases in range of motion of 
individual participants. Reachable workspace more than 
doubled in two participants and functional workspace 
improved up to 28 percent for one participant. The vary-
ing results with regard to range of motion may partly 
be explained by the relative high levels of fatigue during 
testing and by the quality of fit, as participants where the 
Yumen arm fitted best showed the highest improvement 
in range of motion. Although, it is evident that improve-
ments should be made with regard to range of motion, 
the Yumen Arm might still be beneficial to participants 
where the range of motion did not increase, for exam-
ple by assisting in functional activities and by reducing 
fatigue. Optimally, the Yumen Arm should give patients 
the ability to operate within a functional workspace that 
Page 11 of 13Janssen et al. J NeuroEngineering Rehabil           (2021) 18:84  
allows them to perform ADL. With regard to the inabil-
ity to improve range of motion in some participants, we 
expect that muscle strength of these participants was 
insufficient to lift the 30% of the arm weight that remains 
after balancing the arm, and to overcome friction within 
the Yumen Arm, that occurs as a result of misalignment 
with the human joints and balancing error due to non-
linearity and hysteresis in the elastic bands. As a result, 
participants were still not able to lift the arm against 
gravity over the full range of motion while supported by 
the Yumen Arm. Future studies should try to determine 
in advance if users reach the necessary requirements 
and operating thresholds for the Yumen Arm. Operat-
ing thresholds are probably dependent on the ability to 
use compensatory mechanisms and the available muscle 
strength, which is very variable between subjects [25].
The use of trunk movements during the performance 
of daily activities, such as drinking, moving an object and 
using a computer, was reduced in all participants when 
performing the tasks with the Yumen Arm. Trunk move-
ments are often used as compensatory mechanisms to 
allow task performance, which would not be possible 
without compensation [11]. A reduction of trunk move-
ments when performing tasks with the Yumen Arm, may 
indicate that task performance is easier with the Yumen 
Arm as compensatory mechanisms are no longer neces-
sary for task performance. Indeed, observing the partici-
pants we saw more natural movement patterns.
Concerning functional ability, PUL scores of the shoul-
der and elbow dimension showed a median increase of 
11.3% (range 0–19.4%, i.e. 3.5 points) and the ability to 
perform the additional daily activities improved with a 
median of 15% (range 0–50%). In a natural history cohort, 
the PUL score of non-ambulant DMD patients on aver-
age decreases with 4.4 points (1.2 points on the shoulder 
dimension, 2.4 points on the elbow dimension and 0.8 
points on the distal dimension) over a 2-year period [26]. 
These results indicate that functional improvements due 
to the Yumen Arm are similar to 2-years of decline result-
ing from natural disease progression, demonstrating the 
clinical relevance of the improvements. This comparison 
is unfortunately not possible for SMA patients as no nat-
ural history data based on the PUL are available in this 
population. The effect of the Yumen Arm on functional 
ability may improve more over time as participants use 
the device for a longer period of time (learning effect), 
or if they receive specific training on how to use the arm 
support. Therefore, we recommend future studies to look 
into the learning effect of arm supports and the effect of 
training with the arm support, for example with an occu-
pational therapist.
Other studies that examined the effectiveness of (com-
mercially available) dynamic arm supports in NMD 
patients also saw some difficulties regarding the ability of 
passive devices to lift the arm against gravity, especially 
regarding lifting the arm above shoulder level. Hasewage 
et  al. saw that the supportive torque of the Exoskeletal 
meal assistance system III (EMAS III) was not sufficient 
to flex the shoulder upward, and concluded that gravity 
compensation alone is not enough to support the upper 
arm during various activities in people with SMA [27]. 
In addition, Haumont et al. concluded that the Wilming-
ton Robotic EXoskeleton (WREX) was able to increase 
shoulder abduction up to 40 degrees, however the SMA 
patients were still not able to lift shoulder above 50–75 
degrees of flexion [28]. Kramer et  al. concluded that 
users with small muscle force can use the Dynamic Arm 
Support (DAS) to make up and downward movements, 
however gravity compensation for users with very small 
muscle forces may be insufficient due to hysteresis and 
nonlinearity of the system [29]. Although the range of 
motion of the arms when using an arm support is often 
still limited, most studies show that passive arms sup-
ports increase the ability to perform daily activities [4, 
30–33].
Regarding the design of the study, we would like to 
remark that this study only focused on the capacity (what 
someone can do in a controlled environment) and not on 
performance (what someone actually does in daily life). 
For future studies into the effectiveness of arm supports 
we recommend to include performance measures as well, 
as they do not only give insight in functional abilities, but 
also in the ability to effectively use an arm support in a 
daily life environment.
We performed this study in a small and heterogenous 
sample, which may limit the ability to interpret the 
results. The large variability between subjects and the 
study design (case series without group statistics) makes 
it hard to formulate a solid conclusion on the effective-
ness of the Yumen Arm. On the other hand, the large 
variability between subjects and individual description 
of the results gave us important insights in the partici-
pant characteristics of people who can benefit from the 
Yumen Arm, and likely also from other dynamic arm 
supports. It became clear that the ‘one size fits all’ prin-
ciple does not apply for dynamic arm supports, and that 
there is a need for individual adaptable devices. There 
are multiple dynamic arm supports on the market and 
based on individual participants characteristics and 
preferences, different types of arm supports might suit 
some people better than others. Therefore, we recom-
mend people in need of an arm support to try different 
dynamic arm support if they have the chance. Further-
more, we would like to note that the Yumen Arm was not 
designed to fully normalize arm function. It’s dimensions, 
weight and ability to move also restrict task performance 
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in some way. In addition, aesthetics of the Yumen Arm 
should be improved to overcome the negative effects of 
aesthetics on the home use of an arm support. All partici-
pants indicated that the aesthetics of the Yumen Arm can 
be improved. Especially the structure at the back of the 
wheelchair is quite large and does not follow the shape of 
the human body as well as the distal part of the Yumen 
Arm. Future research should focus on further optimiza-
tion of the relation between the functional benefits and 
the restrictive factors of the Yumen arm. Finally, the 
Yumen Arm has some unique features compared to other 
dynamic arm supports, such as bimanual support, free-
dom to move the trunk and ability to reach the wheels 
of a manual wheelchair. Although, the participants indi-
cated to be very positive about these features, we did not 
test the added benefits of these features. We recommend 
future studies to compare the effectiveness of the Yumen 
Arm, to other arm supports to gain insight is the possible 
benefits of these unique features.
Conclusions
This study is one of the first studies describing a range 
of objective measures to examine the effectiveness 
of a dynamic arm support. Based on these measure-
ments we can conclude that the Yumen Arm effectively 
improves arm function in NMD patients, especially in 
people with DMD. However the effectiveness varies a lot 
between individual subjects and the prototype Yumen 
Arm should be improved before it can be commercial-
ized. We provided detailed recommendations for further 
improvement of the Yumen Arm, and possible also for 
the development of other arm exoskeletons. This study 
showed a lot of variability between individual subjects, 
which emphasizes the importance of tuning dynamic arm 
supports based on individual user characteristics, such as 
scoliosis, functional capacity and muscle strength.
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